Futura Medical (LON:FUM) Stock Price Down 2.2% – Time to Sell?

Futura Medical plc (LON:FUM) was down 2.2% on Thursday . The company traded as low as GBX 2.09 and last traded at GBX 2.20. Approximately 1,432,718 shares were traded during mid-day trading, an increase of 25% from the average daily volume of 1,149,129 shares. The stock had previously closed at GBX 2.25.

Futura Medical Trading Down 14.6%

The stock has a market cap of £4.11 million, a P/E ratio of -0.65 and a beta of 1.25. The company has a 50 day simple moving average of GBX 4.05 and a 200 day simple moving average of GBX 7.65.

Futura Medical (LON:FUM) last posted its quarterly earnings results on Tuesday, September 30th. The company reported GBX (2.17) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 56.44% and a negative net margin of 44.64%. As a group, sell-side analysts expect that Futura Medical plc will post 2.8486672 earnings per share for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women.